Royal Bank of Canada reaches agreement over Enron case

The Royal Bank of Canada (RBC) has reached a settlement agreement with Enron, the Enron creditors’ committee and Dutch firm Rabobank, resolving aspects of a share transaction known as ‘Cerberus’. The transaction also involved the use of total return swaps (TRSs) for hedging purposes. Under the terms of last month’s settlement, RBC will receive a payment valued at around $195 million plus interest.

The settlement relates to the proceeds of the sale of 11.5 million shares ofcommon stock of Enron affiliate EOG Resources, a publicly traded company. Theshares were the subject of the Cerberus transaction, which closed in November2000.

RBC entered into a subsequent TRS agreement with Rabobank, under which the bankassumed the credit risk of the transaction and was required to pay RBC $517 millionplus interest in June 2002. Rabobank refused to honour the transaction, whichresulted in litigation

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

The future of life insurance

As the world constantly evolves and changes, so too does the life insurance industry, which is preparing for a multitude of challenges, particularly in three areas: interest rates, regulatory mandates and technology (software, underwriting tools and…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here